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 Abstract 
Nails drug delivery system (NDDS) is an important delivery system in mammals, in which their nails are highly 
affected by the fungal diseases. Disorders of the nail unit range from relatively innocuous conditions such as pigmentation 
in heavy smokers, to painful and debilitating states where the nail unit can be dystrophied, hypertrophied, inflamed, 
infected etc. The human nail forms a resistant barrier to the topical penetration of drugs. Thus, treatment of nail disorders, 
such as fungal infections, remains a challenge because of the difficulty encountered in achieving therapeutic concentrations 
of drugs at the site of infection, which is often under the nail. Ungual and trans-ungual drug delivery continues to receive 
significant attention due to the need for efficacious topical therapies for onychomycosis given the potential risk of systemic 
adverse effects associated with the conventional oral therapy. To successfully treat nail disorders, applied drugs must 
permeate through the dense keratinized nail plate and reach the deeper layers of the nail plate, nail bed and the nail matrix. 
Physical, chemical and mechanical methods have been used to decrease the nail barrier. This current review include 
anatomy of human nail, nails disorders, factors affecting tans-ungual delivery of drugs and methods used for enhancement 
of drugs penetration into/across the nail. 
Keywords: NDDS, Nail-plate, Nail disorders, Onychomycosis, Trans-ungual. 
1. Introduction  
The physicochemical properties of the human nail 
plate exhibit a marked difference to that of epidermis, 
resulting in very different permeability characteristics. 
Whereas the SC behaves as a lipid barrier to the permeation 
of low MW chemicals, the nail plate exhibits behaviors 
similar to that of a hydrogel with high ionic strength and, 
indeed, the structure of human nail has been likened to a 
hydrophilic gel membrane [1]. The lipid content of the nail 
is reported to be low, at between 0.1– 1%, and the nail is 
much more susceptible to water loss than the lipid-rich skin. 
Despite the reported hydrophilic properties of the nail, 
hydrophobic compounds also have been shown to diffuse 
into and through this barrier. For example, Walters and 
coworkers [2] reported that long chain alcohols also 
permeate through the nail via a lipidic pathway. For 
effective transungual drug therapy, permeation must be 
enhanced. This can be achieved by disrupting the nail plate 
using physical techniques or chemical agents. Alternatively, 
drug permeation into the intact nail plate may be 
encouraged, for example, by iontophoresis or by 
formulating the drug within a vehicle which enables high 
drug partition out of the vehicle and into the nail plate. 
There are several physical techniques that have been shown 
to enhance transungual delivery [3]. They include nail 
abrasion (manual and electrical), acid etching, ablation by 
lasers, microporation, application of low-frequency 
ultrasound and electric currents, and chemicals (thiols, 
sulphides, hydrogen peroxide, urea, water, enzymes). The 
nail is horny structure. Nail plate is responsible for 
penetration of drug across it. As it is hard enough the 
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penetration becomes difficult, only a fraction of topical 
drug penetrates across it. Hence the effective therapeutic 
concentration is not achieved. The nail plate may appear 
abnormal as a result of decreased glow. It is involvement of 
nail bed, reduction of blood supply, physical or chemical 
features of nail bed. As a result variety of diseases occurs. 
These diseases can be cured by achieving desired 
therapeutic concentration of drug by nail drug delivery 
system. The human nail, similar to claws of other mammals 
and protects the delicate tips of fingers and toes against 
trauma, enhances the sensation of fine touch and allows one 
to pick up and manipulate objects. The chemical 
composition of the human nail differs significantly from 
other body membranes. The plate, composed of keratin 
molecules with many disulphide linkages and low 
associated lipid levels, does not resemble any other body 
membrane in its barrier properties – it behaves more like a 
hydrogel than a lipophilic membrane. Disorders of the nail 
unit range from relatively innocuous conditions such as 
pigmentation in heavy smokers, to painful and debilitating 
states where the nail unit can be dystrophied, hypertrophied, 
inflamed, infected etc. Such conditions affect patients 
physically as well as socially and psychologically and can 
seriously affect the quality of life. 
 
2. The nail’s structure 
The nail unit consists of four specialized epithelia 
(fig. 1), the nail matrix, the nail bed, the proximal nail fold, 
and the hyponychium. The nail matrix is a germinative 
epithelium that proliferates and differentiates to produce a 
fully keratinized, multilayered sheet of cornified cells: the 
nail plate. The matrix consists of a proximal and a distal 
region, and because the vertical axes of nail matrix cells are 
oriented diagonally and distally, proximal nail matrix 
keratinocytes produce the upper portion of the nail plate, 
and distal nail matrix keratinocytes produces the lower 
portion. Diseases of the proximal nail matrix result in nail 
plate surface abnormalities, whereas diseases of the distal 
matrix result in abnormalities of the ventral nail plate or of 
the nail free edge. The nail plate is a rectangular, 
translucent, and transparent structure that appears pink 
because of the vessels of the underlying nail bed. The nail 
plate is a thin (0.25–0.6 mm), hard, yet slightly elastic, 
translucent, convex structure and is made up of 
approximately 25 layers of dead, keratinized, flattened cells 
which are tightly bound to one another via numerous 
intercellular links, membrane-coating granules and 
desmosomes. The proximal part of the nail plate of the 
fingernails, especially the thumbs, shows a whitish, opaque, 
half-moon shaped area, the lunula that corresponds to the 
visible portion of the distal nail matrix. The shape of the 
lunula determines the shape of the free edge of the plate. 
The nail plate is firmly attached to the nail bed, which 
partially contributes to nail formation along its length. Nail 
plate and nail bed adhesion is tight until the area of the 
hyponychium, where the nail plate detaches and shows its 
whitish free edge. Proximally and laterally the nail plate is 
surrounded by the nail folds. The horny layer of the 
proximal nail fold forms the cuticle, which intimately 
adheres to the underlying nail plate and prevents its 
separation from the proximal nail fold [4]. Growth rate is 
highly variable among individuals; average values of 3 mm 
per month (fingernails) and 1 mm per month (toenails) are 
used when treating nails. A normal fingernail grows out 
completely in about 6 months while a normal toenail in 
about 12–18 months. Nail growth rate is also highly 
influenced by age (ageing slows the rate), gender (rate is 
higher in males), climate (slower in cold climate), dominant 
hand (growth is faster), pregnancy (faster), minor 
trauma/nail biting (increases growth rate), diseases (can 
increase or decrease rate e.g. growth is faster in patients 
suffering from psoriasis and slower in persons with fever), 
malnutrition (slower rate) and drug intake (may increase or 
decrease) [5-12]. Chemically, the nail plate consists mainly 
of the fibrous proteins, keratins, 80% of which is of the 
„hard‟ hair-type keratin, the remainder comprising the „soft‟ 
skin-type keratin [13]. The keratin fibres are thought to be 
held together by globular, cystine-rich proteins whose 
disulphide links act as glue [14]. The plate also contains 
water at 10–30%, water content is directly related to the 
relative humidity and is important for nail elasticity and 
flexibility [15,16]. 
 
Fig 1: The Nail’s Structure 
2.1 Normal ultrasound anatomy of nail 
The nail ultrasonographic unit can be divided in 
three segments (Fig. 2) 
1. The plate (dorsal and ventral); 2. The matrix; 3. The nail 
bed 
The dorsal and ventral aspects of the nail plate are 
viewed as bilaminar, hyperechoic (white), parallel bands 
with a virtual hypoechoic (dark gray) space between them 
called the interpolate space. The nail bed appears as the 
hypoechoic region under the plate, and the nail matrix is the 
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echoic (soft gray) region at the proximal end of the nail bed 
[17,18]. The nail bed is an extremely vascular and 
longitudinally ridged structure; it receives vascularity from 
the ulnar and radial digital arteries [19]. 
 
Fig 2: Ultrasonography of nail 
 
3. Functions of the human nail 
The nail has evolved phylogenetically with the 
development of manual dexterity. The nails of humans have 
been developed to help grasp and manipulate objects. The 
nails fulfill the more general and indispensable function of 
protecting the terminal phalanx and fingertip from 
traumatic impact. Nails also provide enhancement of fine 
touch and fine digital movements and also aid in scratching 
and grooming. In addition, the nails serve an aesthetic and 
cosmetic purpose through a variety of modifications [20]. 
 
4. Nail’s disorders 
Nails can suffer from a very wide range of 
disorders. The nail plate may appear abnormal as result of, 
a congenital defect, disease of skin with involvement of the 
nail bed, systematic disease, reduction of blood supply, 
local trauma, tumors of the nail fold or nail bed, infection of 
the nail fold and infection of the nail plate. The two most 
common diseases affecting the nail unit are onychomycosis 
and psoriasis of the nails.  
Onychomycosis, responsible for up to 50% of nail 
disorders is a very common problem, affecting 3–10% of 
the population in Europe [21,22]. Most of the infections are 
caused by Trichophyton rubrum, T. inerdigitale. The 
chance of Onychomycosis is higher in older people [23-26]. 
Toe nails are affected more than fingernails [27]. 
Psoriasis is an inflammatory disease of the skin 
and is characterized by epidermal thickening and scaling as 
a result of excessive cell division in the basal layers. It is 
thought that 80% of patients with skin psoriasis also suffer 
from psoriasis of the nail [28]. 
 
Table 1: Nail Disorders and symptoms [29]
 
Nail Disorders Characterization/ Symptoms 
Onychomycosis  Onychomycosis is a fungal infection of the keratinized tissue of the nail plate 
 Yellow-brown patches near the lateral border of the nail 
 The nail plate gradually becomes thickened, broken & irregularly distorted.  
 One or many nails may be affected. 
Psoriasis  Rraw, scaly skin  
 The nail plate become pitted, dry and often crumbles and also appears red, orange or brown, with red spots in the 
lunula.  
 The plate may separate from the nail bed and may  
Onycholysis  division of the distal nail plate from the nail bed 
 It can occur in hypothyroidism, with chemotherapy and pellagra 
Leuconychia  White spots or lines appear on one or more nails. 
Pterygium  Pterygium of the nail typically is the presence of a scarred midline band originating from the proximal nail fold in 
the nail 
Clubbing  Clubbed nails show an increase in the longitudinal and transverse curvature of the nail 
Tinea Unguis,  Also known as ringworm of the nails. 
 Nail thickening, deformity, and nail plate loss. 
Yellow Nail  
Syndrome 
 Nails are over curved, thickened, and opaque yellow to yellowish green. 
Onychatrophia  Atrophy of nail plate. 
 Loss of nail plate luster. 
Onychogryposis  Nail plate become thickened nail plate. 
 Nail plate will curve inward and pinching the nail bed. 
Onychorrhexis  Brittle nails which often split vertically, peel and\or have vertical ridges. 
Onychauxis  Over thickening of the nail plate and may be the result of internal disorders. 
Leuconychia  White lines or spot in the nail. 
 This condition may be hereditary. 
Beaus lines  Horizontal lines of darkened cells and linear depressions.  
Koilonychia  It is usually caused through iron deficiency anemia. 
 These nails show raised ridges and are thin and concave. 
Melanonychia  It is a vertical pigmented band, often described as nail ‘moles’, which usually form in the nail matrix. 
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5. Factors affecting drugs transport into/across 
the nail 
Topical application of a drug formulation onto the 
nail plate, the drug has to enter the nail plate and diffuse 
into the deeper nail layers and possibly into the nail bed. 
Walters et al. found that the nail plate behaves like a 
concentrated hydrogel rather than a lipophilic membrane 
[30]. 
Drug delivery into and through the nail plate is influenced 
by: 
 Physicochemical properties of a drug molecule to be 
applied, 
 Type and nature of formulations 
 Presence of permeability enhancers in the formulations 
 Properties nail and  
 Interactions between the permeant and the keratin 
network of the nail plate.  
Molecular size of drug 
The larger the molecular size, the harder it is for 
drug to diffuse through the keratin network and lower the 
drug permeation. Mertin and Lippold demonstrated the 
decreasing permeability coefficients through human nail 
plate and through bovine hoof membrane with increasing 
molecular size of a series of alkyl nicotinates [31]. 
Hydrophilicity / lipophilicity of drug 
Walters et al studied the permeation of a series of 
homologous alcohols (C1–C12), diluted in saline, through 
avulsed human nail plates. Increasing the chain length from 
one carbon to eight carbon atoms resulted in a decrease in 
permeability coefficient, after which, increasing chain 
length (>C12) resulted in increased permeability 
coefficient. The study by Walters et al. concluded that the 
nail plate is characterized as a hydrophilic gel membrane. 
Nature of Vehicle used in formulation 
The permeability coefficients of alcohols diluted in 
saline through nail plates was five times greater than the 
permeability coefficients of neat alcohols. Water hydrates 
the nail plate which consequently swells. Considering the 
nail plate to be a hydrogel, swelling results in increased 
distance between the keratin fibres, larger pores through 
which permeating molecules can diffuse and hence, 
increased permeation of the molecules. Replacing water 
with a non-polar solvent, which does not hydrate the nail, is 
therefore expected to reduce drug permeation into the nail 
plate [32]. 
pH of  vehicle and solute charge 
The pH of aqueous formulations affect the 
ionization of weakly acidic/basic drugs, which in turn 
influences the drug‟s Hydrophilicity / hydrophobicity, 
solubility in the drug, formulation, solubility in the nail 
plate and its interactions with the keratin matrix. It seems 
that the pH of the formulation has a distinct effect on drug 
permeation through the nail plate. Uncharged species 
permeate to a greater extent compared to charged ones [33, 
34]. 
 
6. Drug penetration enhancement into/across nails 
The importance of nail permeability to topical 
therapeutics as been realized, primarily in the treatment of 
onychomycosis, which affects approximately 50% of the 
population [35]. Topical therapy is highly desirable due to 
its localized effects, which results in minimal adverse 
systemic events and possibly improved adherence. 
However, the effectiveness of topical therapies is limited by 
minimal drug permeability through the nail plate [36]. To 
successfully treat nail disorders, applied drugs must 
permeate through the dense keratinized nail plate and reach 
the deeper layers of the nail plate, nail bed and the nail 
matrix. Physical, chemical and mechanical methods have 
been used to decrease the nail barrier. Within each of these 
broad categories, many techniques exist to enhance 
penetration. Mechanical modes of penetration enhancement 
are typically straightforward, and have the most in vivo 
experience associated with them. In contrast, many of the 
chemical and physical methods discussed are still in the in 
vitro stages of development. Effective penetration remains 
challenging as the nail is believed by some to be composed 
of approximately 25 layers of tightly bound keratinized 
cells, 100-fold thicker than the stratum corneum [37].  
Chemical and physical modes of penetration enhancement 
may improve topical efficacy. Binding to keratin reduces 
availability of the active drug, weakens the concentration 
gradient, and limits deep penetration [38]. Physically, 
removing part of the nail plate by filing reduces the barrier 
that drugs have to permeate through to reach the target 
sites. In clinical trial studies, Pittrof et al. and Lauharanta, 
showed that the physical elimination of part of the nail plate 
prior to the application/reapplication of drug-containing 
formulations was essential for the success of topical 
treatment [39, 40]. It is thought that chemical enhancers act 
by reducing the keratin disulphide bonds which are 
responsible for the integrity of the nail keratins and hence, 
for the barrier properties of the nail plate [41]. 
6.1 Mechanical Methods To Enhance Nail Penetration 
Mechanical methods including nail abrasion and 
nail avulsion have been used by dermatologists and 
podiatrists. Nail abrasion involves sanding of the nail plate 
to reduce thickness or destroy it completely. Sand paper 
number 150 or 180 can be utilized, depending on required 
intensity. Sanding must be done on nail edges and should 
not cause discomfort [42]. Total nail avulsion and partial 
nail avulsion involve surgical removal of the entire nail 
plate or partial removal of the affected nail plate, and under 
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local anesthesia. Keratolytic agents such as urea and 
salicylic acid soften the nail plate for avulsion. Urea or a 
combination of urea and salicylic acid has been used for 
non-surgical avulsion. 
6.2 Chemical Penetration Enhancement 
Chemically, drug permeation into the nail plate 
can be assisted by breaking the physical and chemical 
bonds responsible for the stability of nail keratin. Wang and 
Sun, identified the disulphide, peptide, hydrogen and polar 
bonds in keratin that could potentially be targeted by 
chemical enhancers [43]. The two main ways of increasing 
ungual drug transport, that have been investigated are: (i) 
the use of agents such as urea and salicylic acid, which 
soften nail plates and (ii) the use of sulfhydryl compounds 
such as cysteine which cleave the disulphide linkages of 
nail proteins and destabilize the keratin structure. Thus a 
few chemicals which enhance drug penetration into the nail 
plate are known. 
A. Keratinolytic enzymes 
Keratin filaments and keratinic tissues such as skin 
stratum corneum and ground nail plate are known to be 
hydrolyzed by keratinase [44,45]. Mohorcic et al. 
hypothesized that keratinolytic enzymes may hydrolyze nail 
keratins, thereby weakening the nail barrier and enhancing 
trans-ungual drug permeation [46]. 
B. 2-n-nonyl-1,3-dioxolane 
Hui et al. have showed that 2-n-nonyl-1,3-
dioxolane enhances penetration of econazole into the 
human nail [47]. 
C. N-acetyl-l-cysteine and mercaptan compounds 
Kobayashi et al. demonstrated that N-acetyl-l-
cysteine and 2-mercaptoethanol, in combination, enhanced 
permeability of the antifungal drug tolnaftate into nail 
samples [48]. Hoogdalem et al. evaluated the penetration-
enhancing properties of N-acetyl-l-cysteine with the 
antifungal drug oxiconazole in-vivo [49]. Malhotra and 
Zatz screened nail penetration enhancers, including: 
mercaptan compounds, sulfites, bisulfites, keratolytic 
agents and surfactants in vitro. N-(2-mercaptopropionyl) 
glycine, demonstrated superior penetration enhancement to 
all other compounds, urea acted synergistically to increase 
nail permeation to the greatest extent [50]. 
D. Keratolytic enhancers 
Guerrero et al. described the effect of keratolytic agents 
(papain, urea, and salicylic acid) on the permeability of 
three imidazole antifungal drugs (miconazole, 
ketoconazole, and itraconazole) [51]. Brown et al. 
investigated the effect of two novel penetration enhancers, 
thioglycolic acid a reducing agent and urea hydrogen 
peroxide an oxidizing agent on the in vitro nail permeability 
of penetrants of varying lipophilicity caffeine, 
methylparaben and terbinafine [52]. 
6.3 Physical Penetration Enhancement 
Physical permeation enhancement may be superior 
to chemical methods in delivering hydrophilic and 
macromolecular agents [53]. Several physical methods 
which enhance drug penetration into the nail plate are 
known. 
A. Iontophoresis 
Iontophoresis involves delivery of a compound 
across a membrane using an electric field. Drug diffusion 
through the hydrated keratin of a nail may be enhanced by 
iontophoresis.  Murthy et al. elegantly examined transport 
of salicylic acid across the human nail plate. Murthy 
reported increased transungual glucose and griseofulvin 
flux with higher pH (pH > 5) in anodal iontophoresis [54]. 
Hao and Li performed in vitro iontophoresis experiments on 
human nails with neutral and charged molecules. Anodal 
iontophoresis at 0.3mA enhanced mannitol and urea 
transport compared to passive diffusion. 
Tetraethylammonium ion, a positively charged permeant, 
penetration was significantly enhanced with anodal 
iontophoresis at only 0.1mA (i.e. permeability coefficients 
were 29-fold higher under iontophoretic transport than 
under passive transport) [55]. 
B. Etching 
“Etching” results from surface-modifying 
chemical (e.g. phosphoric acid) exposure, resulting in 
formation of profuse microporosities. Once a nail plate has 
been “etched,” a sustained-release, hydrophilic, polymer 
film drug delivery system may be applied. hot-melt 
extruded films containing ketoconazole had 6-fold greater 
permeation in “etched” nail plates compared with normal 
nail plates. Ketoconazole 0.125% gel alone had a 60% 
higher permeability through “etched” nails than through 
normal nails [56]. Mididoddi et al. determined the influence 
of tartaric acid on bio-adhesion and mechanical properties 
in hot-melt extruded hydroxypropyl cellulose films on 
human nails in vitro [57]. 
C. Hydration and occlusion 
Hydration may increase the pore size of nail 
matrix, enhancing transungual penetration. Diffusivity of 
water and other materials (i.e. drugs) increases as human 
skin becomes more hydrated [58]. Gunt and Kasting 
demonstrated that increasing ambient relative humidity 
from 15% to 100% enhanced permeation of ketoconazole 
by a factor of three in vitro [59]. Grover et al. treated 
onychomycosis with avulsion and topical antifungal therapy 
(ketoconazole 2% cream vs. oxiconazole 1% cream), with 
and without occlusion. The overall efficacy rate was just 
56% (15/27 patients cured); however, 71% of those in the 
occlusion group achieved cure vs. 38% in the non-occlusion 
group [60]. 
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D. Lasers 
A patent has been filed for a microsurgical laser 
apparatus which makes holes in nails, topical antifungals 
can be applied in these holes for onychomycosis treatment 
[61]. 
E. Phonophoresis 
Phonophoresis describes the process by which 
ultrasound waves are transferred though a coupling medium 
onto a tissue surface. The induction of thermal, chemical, 
and/or mechanical alterations in this tissue may explain 
drug delivery enhancement. At a gross level, phonophoresis 
may result in improved penetration through the stratum 
corneum transcellularly, pores in the cell membrane may 
enhance drug diffusion [62]. There exist no studies 
documenting phonophoresis on nail penetration. However, 
it has been used to enhance percutaneous penetration to 
joints, muscle, and nerves. 
F. Ultraviolet light 
A recently submitted patent discusses use of heat 
and/or ultraviolet light to treat onychomycosis [63].  
Photodynamic therapy of onychomycosis with 
aminolevulinic acid is a medical treatment based on the 
combination of a sensitizing drug and a visible light used 
together for destruction of cells. Photodynamic therapy 
based on topical application of aminolevulinic acid is used 
in oncological field [64]. 
 
Table 2: Topical market products of nail disorders 
S. 
No. 
Product's 
Name 
Formulation Drug used Indications Pharmaceutical company 
1 Loceryl ® Nail Film Amorolfine Psoriasis, Leuconychia, Melanonychia Galderma, Switzerland 
2 Curanail 5%  Nail Lacquer Amorolfine Psoriasis, Leuconychia, Melanonychia Galderma, Switzerland 
3 Umecta® Nail Film Urea (40%) Fingernail Psoriasis 
JSJ Pharmaceuticals, 
Charleston 
4 Eco-Nail® Nail Lacquer 
Econazole(5%) + 
SEPA (18%) 
Onychomycosis, Onchodystrophy, 
Onychogryposis 
MacroChem Corporation, 
New York 
5 Zalain® Nail Patch 
Sertaconazole 
Nitrate 
Onychomycosis,  Labtec 
6 
Tazorac® 
0.1% 
Gel Tazarotene Fingernail Psoriasis Allergan Inc, Irvine 
7 AvageTM Cream Tazarotene Fingernail Psoriasis Allergan, Inc. Irvine 
8 Ertaczo® Cream 
Sertaconazole 
Nitrate 
Psoriasis, Leuconychia, Melanonychia 
OrthoNeutrogena, Los 
Angele 
9 
Ciclopirox®, 
8% 
Nail Lacquer Ciclopirox Psoriasis, Onychomycosis 
VersaPharm Incorporated, 
Marietta 
10 Penlac® Nail Lacquer Ciclopirox Psoriasis, Onychomycosis 
Dermik Laboratories Inc., 
Berwyn 
 
7. Advance development in nails delivery 
Apart from the traditional formulations like nail 
lacquers, nail varnish, and nail patches recent technologies 
are introduced in the development of more efficient drug 
delivery. Here some of the recent technologies are listed 
which open the new horizons for drug delivery to the 
human nail. 
 
 
Fig. 3: An assembly to study nail penetration by 
Iontophoresis 
 
a) Electrochemotherapy for Nail disorders 
The goal of this therapy is to develop an active 
method of drug delivery across the nail plate which in turn 
is believed to increase the success rate of topical 
monotherapy and decrease the duration of treatment of nail 
disorders. Currently, the electrically mediated techniques 
for drug delivery across the nail plate are investigated. 
Recently the iontophoretic trans‐nail delivery method 
studied. Iontophoresis was found to enhance the transport 
of drugs across the nail plate significantly. Similar to 
transdermal iontophoresis, the predominant mechanisms 
contributing to enhanced transport of drugs in the case of 
transnail iontophoresis are electrophoresis and 
electroosmosis. Iontophoretic permselectivity of the human 
nail plate and its applicability on the trans‐nail delivery of 
drugs are also under investigation. 
b) Mesoscissioning technology 
Mesoscissioning technology creates a 
micro‐conduit through the skin or nail within a specified 
depth range. Fully open pathways can be painlessly scized 
(cut) through the stratum corneum of the skin or through the 
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nail. Microconduits, 300‐500 microns in diameter, are 
produced within seconds and without sensation. These 
pathways can be used to deliver drugs across the skin 
(proof‐of‐concept in vivo human experiments have shown 
full anaesthesia occurs within 3 minutes through 
microconduits compared with 1+hour through intact 
stratum corneum). Such microconduits also permit access 
for subdermal analyte Extraction (including blood for 
glucose testing). In addition, they reduce the skin electrical 
impedance to less than 1000 ohms for biopotential 
measurements. In nails, microconduits quickly reduce the 
painful pressure of subungual hematoma (black toe) and 
could serve as a prophylactic to prevent such pressure 
build‐up in runner's nails. 
c) Nano Patch Nail Fungus 
NanoPatch Fungus uses AC/DC electrochemistry 
and targeted drug delivery to actively push antifungal drugs 
right through the nail cuticle to the actual location of the 
fungus growth. This would be the first treatment option to 
directly target nail fungus at its source of growth.  
 
8. Conclusion 
The purpose of this review is to explore the 
difficulties in penetration of drug across nail plate & 
enhancement of bioavailability of drugs. Topical therapy is 
highly desirable because of its non-invasiveness and ability 
to target drugs to the site of action, minimizing systemic 
adverse effects and improving patient compliance. Topical 
therapy can be optimized by the use of: (i) potent drugs to 
ensure that effective drug concentrations are achieved at the 
site of action; (ii) drugs with the correct physico-chemical 
properties for permeation into the nail plate; (iii) 
penetration enhancers to facilitate ungual drug permeation; 
and by (iv) appropriate formulations which aid ungual drug 
uptake, are easy to use, and which stay in contact with nail 
plates, releasing drugs continuously over long periods of 
time. Drug transport into the nail plate can be assisted by 
filing the nail plate before topical application of drug 
formulations as well as by the use of chemical enhancers. 
Physical, chemical and mechanical methods have been used 
to decrease the nail barrier. Compounds containing 
sulfhydryl groups, such as acetylcysteine, mercaptoethanol, 
have shown promise as ungual penetration enhancers. 
These compounds reduce, thus cleave the disulphide 
linkages which contribute to the stability of nail proteins. 
The barrier properties of the nail plate structure are thus 
compromised and drug uptake into the nail is enhanced. 
The field of ungual drug delivery following topical 
application is relatively young and more research in this 
field is needed to resolve the conflicting reports on the 
physico-chemical parameters that influence ungual drug 
permeation and to find and characterize new penetration 
enhancers and delivery vehicles. 
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